EP2321341A2

Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders

Abstract

This record has no abstract on file.

Term

2.8 yearsto projected expiry

Projected expiry 16 July 2029, counted from filing; an application has no term until it is granted.

171 members in 13 offices

This recordMember, by publication date3 more offices are in the list below

Members171

Family members, oldest first
Document	Office	Kind
US937705A	United States of America	A	1909-10-19
AU2008261102A1	Australia	A1	2008-12-11
CA2688161A1	Canada	A1	2008-12-11
CA3089569A1	Canada	A1	2008-12-11
WO2008151257A2	World Intellectual Property Organization (WIPO)	A2	2008-12-11
US2009048175A1	United States of America	A1	2009-02-19
WO2008151257A3	World Intellectual Property Organization (WIPO)	A3	2009-03-05
AU2009256156A1	Australia	A1	2009-12-10
AU2009256157A1	Australia	A1	2009-12-10
CA2726913A1	Canada	A1	2009-12-10
CA2726917A1	Canada	A1	2009-12-10
CA2930674A1	Canada	A1	2009-12-10
WO2009149278A1	World Intellectual Property Organization (WIPO)	A1	2009-12-10
WO2009149279A2	World Intellectual Property Organization (WIPO)	A2	2009-12-10
AU2009270833A1	Australia	A1	2010-01-21
CA2730603A1	Canada	A1	2010-01-21
WO2009149279A3	World Intellectual Property Organization (WIPO)	A3	2010-01-21
WO2010009319A2	World Intellectual Property Organization (WIPO)	A2	2010-01-21
MX2009013293A	Mexico	A	2010-02-15
US2010069306A1	United States of America	A1	2010-03-18
EP2170930A2	European Patent Office (EPO)	A2	2010-04-07
US2010093635A1	United States of America	A1	2010-04-15
WO2009149278A8	World Intellectual Property Organization (WIPO)	A8	2010-04-22
US2010120694A1	United States of America	A1	2010-05-13
US2010152118A1	United States of America	A1	2010-06-17
EA200971130A1	Eurasian Patent Organization (EAPO)	A1	2010-06-30
IL202510A0	Israel	A0	2010-06-30
IL202510D0	Israel	D0	2010-06-30
CN101772513A	China	A	2010-07-07
JP2010530849A	Japan	A	2010-09-16
WO2010009319A3	World Intellectual Property Organization (WIPO)	A3	2010-09-16
HK1142085A	Hong Kong, China	A	2010-11-26
HK1142085A1	Hong Kong, China	A1	2010-11-26
US7879802B2	United States of America	B2	2011-02-01
EP2296685A1	European Patent Office (EPO)	A1	2011-03-23
EP2321341A2This record	European Patent Office (EPO)	A2	2011-05-18
EP2328910A2	European Patent Office (EPO)	A2	2011-06-08
CA2782691A1	Canada	A1	2011-06-09
CA3068416A1	Canada	A1	2011-06-09
WO2011069038A2	World Intellectual Property Organization (WIPO)	A2	2011-06-09
US2011160120A1	United States of America	A1	2011-06-30
JP2011522828A	Japan	A	2011-08-04
JP2011523662A	Japan	A	2011-08-18
US8034782B2	United States of America	B2	2011-10-11
JP2011528375A	Japan	A	2011-11-17
US2011319343A1	United States of America	A1	2011-12-29
WO2011069038A3	World Intellectual Property Organization (WIPO)	A3	2012-03-01
HK1155092A	Hong Kong, China	A	2012-05-11
HK1155092A1	Hong Kong, China	A1	2012-05-11
AU2010325900A1	Australia	A1	2012-06-21
US8207295B2	United States of America	B2	2012-06-26
HK1157366A	Hong Kong, China	A	2012-06-29
HK1157366A1	Hong Kong, China	A1	2012-06-29
EP2170930B1	European Patent Office (EPO)	B1	2012-08-15
US2012220526A1	United States of America	A1	2012-08-30
MX2012006263A	Mexico	A	2012-09-07
EP2506865A2	European Patent Office (EPO)	A2	2012-10-10
DK2170930T3	Denmark	T3	2012-11-05
US2012289460A1	United States of America	A1	2012-11-15
EP2527360A2	European Patent Office (EPO)	A2	2012-11-28
ES2393885T3	Spain	T3	2012-12-28
CN102858361A	China	A	2013-01-02
US8357775B2	United States of America	B2	2013-01-22
US8367800B2	United States of America	B2	2013-02-05
EP2527360A3	European Patent Office (EPO)	A3	2013-02-20
JP2013512923A	Japan	A	2013-04-18
US2013096071A1	United States of America	A1	2013-04-18
US2013116199A1	United States of America	A1	2013-05-09
US8497348B2	United States of America	B2	2013-07-30
EP2170930B3	European Patent Office (EPO)	B3	2013-10-02
US2013274204A1	United States of America	A1	2013-10-17
US8569246B2	United States of America	B2	2013-10-29
CN101772513B	China	B	2013-11-13
EP2527360A9	European Patent Office (EPO)	A9	2013-11-13
US2013310328A1	United States of America	A1	2013-11-21
AU2008261102B2	Australia	B2	2013-11-28
US2014024605A1	United States of America	A1	2014-01-23
ES2393885T7	Spain	T7	2014-01-30
CN103601792A	China	A	2014-02-26
US8664354B2	United States of America	B2	2014-03-04
US8716224B2	United States of America	B2	2014-05-06
US2014135274A1	United States of America	A1	2014-05-15
JP5546451B2	Japan	B2	2014-07-09
EP2328910B1	European Patent Office (EPO)	B1	2014-08-06
AU2009256156B2	Australia	B2	2014-09-18
JP2014185158A	Japan	A	2014-10-02
US2014329738A1	United States of America	A1	2014-11-06
ES2522968T3	Spain	T3	2014-11-19
EA020466B1	Eurasian Patent Organization (EAPO)	B1	2014-11-28
US8901075B2	United States of America	B2	2014-12-02
EP2810951A2	European Patent Office (EPO)	A2	2014-12-10
AU2009256157B2	Australia	B2	2014-12-18
AU2009270833B2	Australia	B2	2015-02-19
US2015057235A1	United States of America	A1	2015-02-26
US8969514B2	United States of America	B2	2015-03-03
EP2810951A3	European Patent Office (EPO)	A3	2015-03-25
EP2506865B1	European Patent Office (EPO)	B1	2015-04-01
ES2540326T3	Spain	T3	2015-07-09
US9089612B2	United States of America	B2	2015-07-28
US2015239934A1	United States of America	A1	2015-08-27

Showing 100 of 171

83 legal events, as 12 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2026-07-10	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2026-04-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2026-04-13	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2026-04-09	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2026-03-25	Gb: european patent ceased through non-payment of renewal feeCeasedGBPC	GBPC	EP
2026-02-03	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2024-10-21	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-10-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-09-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-07-08	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-06-14	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2020-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-03-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-12-18	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20191121 AND 20191127732E	732E	GB
2019-11-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-06-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-06-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-09-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-07-26	Fee paymentPLFP	PLFP	FR
2018-06-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-05-03	Lapsed because of non-payment of the annual feeLapsedMM	MM	BE
2018-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-04-18	Patent lapsedLapsedMM4A	MM4A	IE
2018-03-02	Standard patents granted in hong kongGrantedGR	GR	HK
2018-02-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2018-02-28	Patent ceasedCeasedPL	PL	CH
2018-01-31	No opposition filedOpposition26N	26N	EP
2017-12-29	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2017-12-29	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2017-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-11-23	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2017-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-10-25	Fee paymentPLFP	PLFP	FR
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2017-07-17	Definitive protectionFG2A	FG2A	ES
2017-07-15	Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05	MK05	AT
2017-06-28	Patent invalid in the netherlands as no translation has been filedMP	MP	NL
2017-06-26	Invalidated european patentMG4D	MG4D	LT
2017-04-06	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2017-04-05	Party data changed (patent owner data changed or rights of a patent transferred)RAP2	RAP2	EP
2017-03-22	European patents granted designating irelandGrantedFG4D	FG4D	IE
2017-03-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2017-02-28	European patent takes effect as a national patent in ch/liEP	EP	CH
2017-02-22	Designated contracting statesAK	AK	EP
2017-02-22	European patent grantedGrantedFG4D	FG4D	GB
2017-02-15	Intention to grant announcedINTG	INTG	EP
2017-01-25	Intention to grant announced (deleted)INTC	INTC	EP
2017-01-20	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2017-01-20	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA	STAA	EP
2017-01-13	Information related to intention to grant a patent recordedORIGINAL CODE: EPIDOSNIGR71GRAR	GRAR	EP
2017-01-13	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2017-01-13	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA	STAA	EP
2016-12-16	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deletedORIGINAL CODE: EPIDOSDIGR1GRAJ	GRAJ	EP
2016-12-16	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA	STAA	EP
2016-09-14	Intention to grant announcedINTG	INTG	EP
2016-08-17	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2015-03-04	First examination report despatched17Q	17Q	EP
2012-06-29	Requests to designate patent in hong kongDE	DE	HK
2011-10-26	Request for extension of the european patent (deleted)DAX	DAX	EP
2011-05-18	Request for examination filed17P	17P	EP
2011-05-18	Designated contracting statesAK	AK	EP
2011-05-18	Request for extension of the european patentAX	AX	EP
2011-04-15	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders

Abstract

Term

Members171

Over the term

Events

Numbers

Titles3

Classification

Designated states39